Home Blog Page 3076

HIMSS APAC 2025: Malaysian Health Minister Visits GuidelineX Exhibition to Explore AI Clinical Decision Support System

KUALA LUMPUR, Malaysia, July 22, 2025 /PRNewswire/ — Dr. Dzulkefly Ahmad, Minister of Health of Malaysia, visited the GuidelineX exhibition at HIMSS APAC 2025, where he engaged in comprehensive discussions on AI-powered clinical decision support systems (CDSS). The minister examined the practical applications of GuidelineX’s technology, which has supported 61 million inpatient visits and facilitated 1.4 billion outpatient visits annually across China, representing 25% and 33% of the national patient visits to hospitals, respectively.

Dr. Ahmad noted Malaysia’s ongoing efforts in digital health and took interest in GuidelineX’s reported outcomes, including a 46% reduction in hospital-acquired venous thromboembolism (HA-VTE) rates through AI-based alerting systems. Notably, GuidelineX’s AI  screened 10,233 individuals for Fabry disease within three months, efficiently identifying five confirmed cases and two individuals with GLA gene VUS, showcasing the tremendous potential of AI-CDSS in advancing early detection and population health strategies. “To succeed, we must look both inward and outward,” stated Dr. Ahmad, highlighting that digital health transformation involves “more than just deploying systems – it requires a holistic approach to innovation and patient care.”

Malaysia’s Minister of Health, Dr. Dzulkefly Ahmad, Visited the GuidelineX Booth.
Malaysia’s Minister of Health, Dr. Dzulkefly Ahmad, Visited the GuidelineX Booth.

As a leading AI clinical adoption provider in Asia, GuidelineX offers next-generation, cloud-native solutions that have been implemented in 1,061 large hospitals by the end of 2024, including 50% of the country’s top 100 major hospitals. Dr. Jenny Shao, Chief Medical Officer of GuidelineX, presented the applications of AI in chronic disease management and oncology clinical pathways, to which the minister responded with recognition of the significant potential that AI holds for enhancing clinical healthcare.

GuidelineX positions AI as an intelligent and specialized assistant deeply integrated into clinical workflows, rather than a rigid tool requiring physician adaptation. This philosophy has driven its product ecosystem to deliver actionable clinical AI recommendations adopted 1 billion times annually by clinicians worldwide. The Minister expressed profound agreement with this product vision during the demonstration.

Media Contact: 

Xuan Hua
+86-18813160136
huaxuan@guidelinex.com

3CLogic and ScreenMeet Expand Partnership to Elevate ServiceNow-Powered Customer and IT Support with Voice AI and Rich Video Collaboration

Latest partnership helps leading Managed Services Provider, Solugenix, deliver smarter experiences powered by AI, Voice, and remote support to their restaurant franchise customers.

ROCKVILLE, Md., July 22, 2025 /PRNewswire/ — 3CLogic, the leading AI-powered contact center platform purpose-built for ServiceNow®, and ScreenMeet, the only ServiceNow native provider of AI and video-based remote support, today announced the expansion of their strategic partnership. The collaboration between both ServiceNow-certified Build partners will focus on delivering unified Voice AI and Video experiences across both IT, HR, and Customer Support for enterprises leveraging the Now Platform. 

Per a recent Gartner1 report, as GenAI continues to evolve, enterprises will likely shift from traditional multichannel to seamless multimodal experiences—placing voice and video at the core. By embedding advanced Voice AI self-service, enterprise-grade contact center capabilities, and rich video collaboration directly into the ServiceNow platform, 3CLogic and ScreenMeet empower IT Support Managers, Contact Center Directors and Customer Experience leaders to resolve incidents faster, reduce frustration, and drive higher satisfaction.

“Our customers demand a single pane of glass for all support interactions,” explains Denis Seynhaeve, CEO of 3CLogic. “By pairing our Voice AI and Contact Center platform with ScreenMeet’s video collaboration, we’re turning ServiceNow into the ultimate support hub—helping enterprises delight customers and slash resolution times.”

Key benefits of the 3CLogic + ScreenMeet collaboration for ServiceNow:

  • Unified Voice AI, Intelligent Routing & Rich Video Collaboration – 3CLogic and ScreenMeet together transform ServiceNow into an end‑to‑end support hub by embedding Voice AI bots, self‑service automation, and advanced IVR routing alongside in‑context video, co‑browsing, and screen‑share. Routine inquiries are handled by AI with seamless hand‑offs to live agents routed to the right skill group, while ScreenMeet’s video tools let agents see exactly what users see, whether troubleshooting a POS failure or guiding through software setup.
  • Seamless Integration with ServiceNow Workflows– Both 3CLogic and ScreenMeet integrate with ServiceNow, leveraging the platform’s AI capabilities and existing digital channels. This ensures that voice- and video-driven interactions automatically trigger ServiceNow tasks, updates, and analytics – delivering end-to-end traceability and insight.
  • Agent Automation & Optimization – By combining 3CLogic’s automated call recordings, real‑time call transcriptions, and GenAI‑powered call summarizations – each auto‑associated with the correct ServiceNow record – with ScreenMeet’s AI summarization of video chat and screen‑share sessions, agents no longer spend time jotting notes or hunting down recordings. Together, 3CLogic and ScreenMeet populate agent work notes and update record (e.g., Incident, Case, etc.) histories automatically, freeing support teams to focus on complex issues rather than manual documentation.
  • Enhanced Reporting & Insights – 3CLogic feeds real‑time contact‑center metrics – call volumes, queue health, sentiment scores – directly into ServiceNow dashboards, while ScreenMeet captures and stores session data, system info, recordings, and AI‑generated summaries in‑platform. This unified data model delivers consolidated wallboards and reports, giving managers a holistic view of voice and video interactions and actionable insights to continuously refine workflows and drive performance

Real-World Use Case
“By using 3CLogic and ScreenMeet together, we look forward to seamlessly routing every support request into a single, unified flow, instantly connecting customers with agents and launching live video sessions without any channel hopping,” explains Chris Antonelli, EVP at Solugenix, a leading managed services provider catering to the world’s largest restaurant franchises. “The joint solution lets our team see exactly what the customer sees, guide them step by step, and resolve issues faster – all within ServiceNow for a truly effortless support experience.”

“Video chat dramatically shrinks the time to resolution,” adds Lou Guercia, COO of ScreenMeet. “When an agent can see the exact device, screen, or environment, they eliminate lengthy back-and-forth. Together with 3CLogic on ServiceNow, we deliver a unified experience that’s fast, efficient, and secure.”

Availability and Next Steps
The combined 3CLogic + ScreenMeet integration is generally available today. Enterprise organizations running ServiceNow IT Service Management, CRM and Industry Workflows, or Employee Service Center can engage their ServiceNow account teams or visit the 3CLogic and ScreenMeet websites to learn more.

In addition 3CLogic and ScreenMeet will be sponsors and attend a number of the upcoming ServiceNow Fall events including the ServiceNow AI Summits in Atlanta and Dallas as well as the World Forum events in New York, Chicago, Munich, London, and Amsterdam.

About 3CLogic
3CLogic transforms customer and employee experiences with its patented and award-winning AI-powered cloud contact center solutions purpose-built to enhance today’s leading CRM and Customer Service Management platforms. Globally available and leveraged by the world’s leading brands, its offerings empower enterprise organizations with innovative capabilities, such as intelligent self-service, Generative AI, Conversational AI, agent automation & coaching, and AI-powered sentiment analytics — all designed to lower operational costs, maximize ROI, and deliver better, faster, and more personalized interactions for IT, employee, and customer service. For more information, please visit www.3clogic.com.

About ScreenMeet
ScreenMeet is a cloud‑native remote support and collaboration platform. Designed to embed seamlessly into leading CRM, AEM and ITSM systems – like ServiceNow, Tanium and Salesforce – ScreenMeet empowers enterprises with in‑browser voice, video, co‑browsing, and remote takeover capabilities, eliminating downloads and manual workflows. Trusted by over 50,000 agents and 400 million end users worldwide, ScreenMeet delivers secure, AI‑enhanced support experiences that modernize contact centers and IT help desks for the digital era. For more information please visit www.screenmeet.com.

1 https://www.gartner.com/en/newsroom/press-releases/2024-12-11-gartner-predicts-that-30-percent-of-fortune-500-companies-will-offer-service-through-only-a-single-ai-enabled-channel-by-2028

 

3CLogic Voice AI & Contact Center and ScreenMeet AI-powered Video Remote Support for ServiceNow.
3CLogic Voice AI & Contact Center and ScreenMeet AI-powered Video Remote Support for ServiceNow.

 

First-of-its-kind Venture Capital Programme in Asia launches as NUS commits S$150 million to boost growth of deep tech start-ups

  • NUS will invest S$50 million (US$39 million) in selected venture capital (VC) firms to provide structured support for NUS tech start-ups.
  • S$100 million will be committed to an autonomous investment fund focused on NUS-affiliated start-ups, with the flexibility to invest alongside selected VC partners.

SINGAPORE, July 22, 2025 /PRNewswire/ — Asia is grappling with a prolonged funding winter, with venture capital investments falling sharply to a 10-year low of S$85 billion (US$66 billion). With a five per cent decline from 2023, early-stage funding totalled less than S$38 billion (US$29 billion) in 2024[1]. To address the critical funding and mentorship gaps faced by tech start-ups, NUS Enterprise, the entrepreneurial arm of the National University of Singapore (NUS) — flagship comprehensive research university in Singapore, is committing S$150 million (US$116 million) to launch the NUS VC Programme.

The initiative aims to enhance support for early-stage tech innovation by focusing on high-potential ventures within the NUS ecosystem, including start-ups from the National Graduate Research Innovation Programme (National GRIP). National GRIP empowers innovators to transform lab-based research discoveries into globally competitive, market-ready ventures.

“As the region faces a sharp pullback in venture capital activity, we see the new NUS VC Programme — the first of its kind initiative by a university in Asia — as a critical enabler. Research-based start-ups face distinct challenges, including R&D cycles that are much longer than traditional start-ups, making them especially vulnerable in today’s cautious investment environment. This programme brings together capital, strategic partnerships, and specialised venture expertise to create a more resilient path from lab to market,” said Professor Tan Eng Chye, NUS President.

Beyond capital: Money and expertise

The programme comprises two key components.

First, NUS will commit S$50 million (US$39 million) over the next three years in selected venture capital firms with strong track records in early-stage deep tech investments. These firms will provide structured, hands-on support to start-ups, including time, expertise, and access to their networks to help them scale effectively.

The first two VC partners are Granite Asia, a leading multi-asset investment platform with a 25-year track record of backing breakthrough technology ventures globally, and 4BIO Capital, a specialist life sciences investor focused on advanced therapeutics. (Refer to Annexes A and B for details on the structured initiatives developed by NUS in collaboration with these partners and their quotes.)

Second, NUS will set aside S$100 million (US$78 million) for co-investments alongside these VC partners. These co-investments will be targeted at NUS-affiliated start-ups.

Complementing National GRIP with expert VC support for NUS start-ups

Many National GRIP start-ups are still in the early stages of technological readiness and require continued, strategic support to advance from lab to market. The NUS VC Programme complements the National GRIP framework by addressing this need for downstream venture development. While GRIP currently provides up to S$250,000 (US$194,000) in seed funding per start-up, the VC Programme focuses on accelerating post-seed growth and preparing ventures for external capital.

What sets this effort apart is the direct engagement with leading venture capital firms selected not only for their track records, but also for their market access in global innovation hubs. By combining capital with deep venture expertise, the programme offers structured support including mentorship, investor feedback, market entry, fundraising networks, and operational guidance.

“National GRIP is an important first step in helping deep tech start-ups take root,” said Dr Tan Sian Wee, NUS Senior Vice President (Innovation & Enterprise). “The VC Programme builds on this by pairing promising ventures with globally connected investors, enabling a more complete pathway to scale and commercial success. This is essential given that most start-ups struggle to move beyond early-stage innovation toward impactful, real-world deployment.”

For media enquiries, please contact:

For NUS Enterprise (APRW on behalf of NUS Enterprise):
Aye Mya Mya Toe (Mya)
+65 9237 4813
mya@aprw.asia

Bijal Doshi
+65 9754 7691
bijal@aprw.asia

 

LG AI Research Showcases ‘EXAONE Ecosystem’ at LG AI Talk Concert 2025

Pioneering AI Transformation from Bio to Business Intelligence

SEOUL, South Korea, July 22, 2025 /PRNewswire/ — LG AI Research hosted its “LG AI Talk Concert 2025” today at the LG Sciencepark Convergence Hall in Magok, Seoul, showcasing the evolution of its EXAONE ecosystem. The event highlighted the culmination of five years of AI development, featuring advanced AI models and services designed for real-world industrial applications.

Woohyung Lim, Co-President of LG AI Research, outlined future plans, stating, “LG AI Research will secure global competitiveness based on our proprietary foundation model, go beyond AI model development to apply it in various industrial fields, thereby achieving both versatility and specialization, and create an AI ecosystem with global partners.” Following this, Honglak Lee, Co-President of LG AI Research and CSAI (Chief Scientist of AI), mentioned the recently unveiled EXAONE.

EXAONE 4.0 is leading hybrid AI model developed in Korea. EXAONE Path 2.0 is a precision medical AI model capable of reducing disease diagnosis time from two weeks to under one minute.

A highlight of LG AI Talk Concert 2025 was the debut of EXAONE 4.0 VL (Vision Language), a sophisticated multimodal AI model adept at comprehensively understanding complex professional documents, images, and molecular structures. In performance comparisons, EXAONE 4.0 VL demonstrated superior performance compared to Meta’s Llama 4 Scout model. Mr. Lee emphasized that EXAONE 4.0 VL will serve as the “eyes” of the EXAONE model.

Following this, Jungkyu Choi, leader of the AI Agent Group at LG AI Research, successively unveiled EXAONE-based enterprise AI agents that have completed LG’s internal validation: ChatEXAONE, EXAONE Data Foundry, and EXAONE On-Premise. Mr. Choi stated, “ChatEXAONE, the AI agent for LG employees, has obtained ISO certification for its ability to process even national core technology documents, demonstrating its potential for expansion into enterprise-exclusive services requiring high security.” He further added, “Following the release of EXAONE 4.0, we have expanded the model’s licensing scope to include educational purposes, preparing to enable students from elementary to university levels to freely utilize EXAONE.”

LG AI Research also introduced key technologies designed to accelerate the creation of specialized AI models for various professional domains. The newly unveiled ‘EXAONE Data Foundry’ is a platform that functions as an AI factory for producing high-quality data. EXAONE Data Foundry dramatically streamlines data generation, enabling a single individual to complete in one day what would typically require 60 experts working for three months. Validation projects conducted by LG AI Research with LG affiliates and national institutions have demonstrated a minimum 1,000-fold increase in data productivity and an average 20% improvement in data quality compared to existing methods.

LG AI Research concluded its EXAONE ecosystem showcase by introducing ‘EXAONE On-Premise’, a solution built entirely with proprietary Korean technology, from AI semiconductors to models. EXAONE On-Premise is a full-stack solution that establishes enterprise agents in an independent environment, enabling companies to utilize EXAONE models without security concerns. LG AI Research also highlighted its key domestic and international partners within the EXAONE ecosystem, signaling the potential for diversifying its AI B2B business model.

LG AI Talk Concert 2025 also featured a presentation by Professor Minkyung Baek of Seoul National University’s Department of Life Sciences, who discussed the progress of “Next-Generation Protein Structure Prediction AI” for AI-driven drug discovery. Professor Baek detailed the development of an AI model that surpasses Google DeepMind’s AlphaFold, potentially marking a new era in disease treatment.

Arman Sahovic, APAC Head of Data Platform Solutions at the London Stock Exchange Group (LSEG), introduced business intelligence services developed with EXAONE. Mr. Sahovic explained that LSEG and LG AI Research are collaborating to create a service that predicts investment asset return trends and generates reports based on LSEG’s data, news, and disclosure information, thereby aiding investment decisions globally.

LG AI Research also highlighted its pioneering and impactful journey since its establishment in December 2020, challenging uncharted territories to solve complex industrial problems and realize the value of AI:

  • In 2021, LG AI Research first demonstrated its AI technological competitiveness by securing first place in the SQuAD leaderboard, an AI English reading comprehension competition.
  • In December 2021, it released EXAONE 1.0, Korea’s first multimodal AI model, marking a significant step in developing proprietary AI foundational models.
  • In 2022, it achieved a world first by showcasing collaborative works between AI and human fashion designers at New York Fashion Week, earning a Gold Award at the New York Festivals Advertising Awards for its innovation.
  • In 2023, LG AI Research became the first Korean entity to establish an AI ethics implementation partnership with UNESCO, solidifying its position as a leader in global AI ethics governance through various initiatives.
  • In August 2024, it released EXAONE 3.0, Korea’s first open-source model for research, promoting Korea’s AI capabilities globally. In December of the same year, EXAONE 3.5 was the only Korean AI model to be included in Stanford University’s AI Report.

This year, LG AI Research continues its relentless pursuit of innovation, releasing EXAONE Deep in March, Korea’s first reasoning AI model, followed by EXAONE 4.0 in July, Korea’s first hybrid AI model combining general and reasoning models.

The combined download count for LG AI Research’s large language models (LLMs) – EXAONE 3.0, EXAONE 3.5, the reasoning AI model EXAONE Deep for agentic AI, and the hybrid AI model EXAONE 4.0 – have exceeded 5 million, a record high among Korean AI companies.

Co-President Honglak Lee articulated LG AI Research’s future ambition, stating, “The evolution of agentic AI directly leads to physical AI, a technology that transforms the real world. LG AI Research will accelerate the development of physical AI technology, enabling AI to perceive, judge, and alter actual environments.”

LG AI Research remains committed to continuous innovation, venturing into new domains to create unprecedented value and elevate Korea’s AI competitiveness to a global standard.

About LG Group  

LG Group is a leading global company representing South Korea, offering innovative products and services across various industries such as electronics, chemicals, telecommunications, and energy. Established in 1947, LG Group has grown into a world-renowned brand through its activities in these diverse fields. The company is committed to continuous research and development, focusing on innovation to enhance the quality of life for its customers. Emphasizing its role as a socially responsible enterprise, LG Group is striving to strengthen its competitiveness in the global market and achieve sustainable growth through its future portfolio in areas like AI, Bio, and Cleantech. The company is dedicated to realizing its vision of being a business that provides value to customers and society, pursuing this mission with unwavering determination. For more information, visit https://www.lgcorp.com 

About LG AI Research 

Launched in December 2020 as the artificial intelligence (AI) research hub of South Korea’s LG Group, LG AI Research aims to lead the next epoch of artificial intelligence (AI) to realize a promising future by providing optimal research environments and leveraging state-of-the-art AI technologies. And LG AI Research developed its large-scale AI, EXAONE, a 300 billion parametric multimodal AI model, in 2021. EXAONE, which stands for “Expert AI for Everyone,” is a multi-modal large-scale AI model that stands out from its peers due to its ability to process both language and visual data. With one of the world’s largest learning data capacities, LG AI Research aims to engineer better business decisions through its state-of-the-art artificial intelligence technologies and its continuous effort on fundamental AI research. For more information, visit https://www.lgresearch.ai 

Tag along with Jay at CISCE: The secret ingredient in global agriculture? Friends!

BEIJING, July 22, 2025 /PRNewswire/ — This is a report from China.org.cn:

Video Link: https://youtu.be/1Glsl4uuSfE

British visitor Jay Ian Birbeck explored the green agriculture section of the third China International Supply Chain Expo (CISCE), an event showcasing the full breadth of the global supply chain, held in Beijing from July 16 to 20.

Jay visited his favorite section of the expo — the Green Agriculture Chain. As always, it was packed with exhibitors, including many international companies and brands, highlighting the event’s growing global reach. This year, the section received a major upgrade, showcasing premium supply chain displays from places like Qinghai, Ningxia, Heilongjiang, and Xinjiang, along with a rich variety of local specialties from across China.

While savoring the local delicacies and exploring the vibrant exhibits, Jay unexpectedly reunited with an Arab friend he had met during the inaugural CISCE. For them, the expo is not just a place to reconnect with old friends, but also a platform where brands and exhibitors from around the world come together to build new friendships, uncover opportunities, and forge win-win collaborations.

One such example is the CISCE success story of JiShuo Technology and Jinma Weighing Apparatus. After connecting at the first two editions of the expo, the two companies gained a deeper understanding of each other’s products and operations. This mutual trust paved the way for a partnership, culminating in a strategic agreement signed at this year’s expo to co-develop a more reliable and streamlined traceability and trading system for livestock products.

At the McDonald’s China booth, Jay discovered something new: the company had invited 11 upstream and downstream supply chain partners to jointly exhibit, each showcasing their operations and achievements in China. During the expo, McDonald’s China officially launched the “McDonald’s China Chain Pledge,” a collaborative vision for the future anchored in its “three-legged stool” philosophy — representing the brand, employees, and suppliers. Together, they aim to drive sustainable, long-term success through strong partnership and shared goals.

At the Louis Dreyfus Company (LDC) booth — a first-time participant at CISCE — Jay experienced an innovative interactive display called the “Seed Tree.” By scanning a QR code, visitors can trace a product’s journey from farm to fork, gaining full transparency into its supply chain from origin to end consumers. Sharing her hopes for the expo, the LDC representative expressed excitement about meeting new partners, exploring new business opportunities, and working together to build safe, sustainable food and agricultural supply chains — for the benefit of current and future generations.

Long-term relationships are growing stronger, while new partnerships continue to develop. The green agriculture family just keeps getting bigger, bringing even more energy, diversity, and potential to the entire exhibition. The larger the network of friends, the stronger the supply chain grows. That’s what the supply chain expo is all about — and why it’s such a can’t-miss event!

Tag along with Jay at CISCE: The secret ingredient in global agriculture? Friends!

http://www.china.org.cn/2025-07/21/content_117988412.shtml

Photography Works Showcasing Xizang’s Majestic Nature

BEIJING, July 22, 2025 /PRNewswire/ — A news report from China.org.cn on photography works of Xizang:


Photography Works Showcasing Xizang’s Majestic Nature

“Tashi Delek!” The 5th China Xizang Internet Photography & Video Festival has concluded, and we are thrilled by the enthusiastic response. We received over 140,000 submissions from photographers and videographers worldwide. Each photo, video, and animation offered a unique perspective of Xizang’s magnificent landscapes, blending snow-capped mountains, crystal-clear lakes, and expansive grasslands, all bathed in the stunning natural light that only this place can offer.

This collection celebrates a key theme: Xizang, known as the “Roof of the World”, is a land of boundless natural beauty. These works capture the essence of Xizang’s mountains, lakes, and valleys, showcasing their awe-inspiring grandeur and mysterious allure. Photographers have immortalized not only the landscapes but also the spirit of the people. Their love for life and reverence for nature resonate deeply through the lens.

We are excited to announce that the awards ceremony will be held on July 26th in Lhasa. We invite people from around the world to join us for this special event, where we will honor the creativity and dedication behind these incredible works. Come immerse yourself in the beauty and spirit of Xizang, and we look forward to seeing you in Lhasa!

The 5th China Xizang Internet Photography & Video Festival 
http://guoqing.china.com.cn/node_9013219.htm

Photography Works Showcasing Xizang‘s Majestic Nature
https://www.facebook.com/chinaorgcn/videos/1036806441818197/
https://x.com/chinaorgcn/status/1943215547149357405

SEMI Reports Global Total Semiconductor Equipment Sales Forecast to Reach $125.5 Billion in 2025

AI and Leading-edge Technology Transitions are Expected to Drive Three Consecutive Years of Growth through 2026

MILPITAS, Calif., July 22, 2025 /PRNewswire/ — SEMI today announced that global sales of total semiconductor manufacturing equipment by original equipment manufacturers (OEMs) are forecast to set a new industry record of $125.5 billion in 2025, a 7.4% year-on-year increase, according to its Mid-Year Total Semiconductor Equipment Forecast – OEM Perspective. Semiconductor manufacturing equipment growth is expected to continue in 2026, with sales projected to reach a new high of $138.1 billion, driven by leading-edge logic, memory and technology transitions.

SEMI 2025 Mid-Year Total Equipment Forecast By Segment
SEMI 2025 Mid-Year Total Equipment Forecast By Segment

“Following strong growth in 2024, global semiconductor manufacturing equipment sales are forecast to expand again this year and set a new record in 2026,” said Ajit Manocha, SEMI president and CEO. “While the semiconductor industry is closely monitoring macroeconomic uncertainty, AI-fueled demand for chip innovations is driving investments in capacity expansions and leading-edge production.”

Semiconductor Equipment Sales by Segment 

After registering a record $104.3 billion in sales last year, the Wafer Fab Equipment (WFE) segment, which includes wafer processing, fab facilities and mask/reticle equipment, is projected to increase 6.2% to $110.8 billion in 2025. This upward revision from SEMI’s 2024 Year-End Equipment Forecast of $107.6 billion is largely driven by increased sales to foundry and memory applications. Looking ahead to 2026, WFE segment sales are projected to expand 10.2%, reaching $122.1 billion. The growth is attributed to capacity expansions in leading-edge logic and memory to support AI applications, as well as ongoing process technology migrations across major segments. 

The back-end equipment segment is anticipated to continue its strong recovery that began in 2024. Following that year’s robust 20.3% year-on-year growth, sales of semiconductor test equipment are projected to rise another 23.2% in 2025 to a new record of $9.3 billion. Assembly and packaging equipment sales grew 25.4% in 2024 and are forecast to increase 7.7% to $5.4 billion in 2025. Back-end equipment segment expansion is expected to continue in 2026, with test equipment sales rising 5.0% and assembly and packaging sales increasing 15.0%, marking three consecutive years of growth. The expansion is driven by significant increases in the complexity of device architectures and the robust performance requirements for AI and high-bandwidth memory (HBM) semiconductors. However, growth in this segment is partially offset by continued weakness in the automotive, industrial and consumer end markets.

WFE Sales by Application

WFE sales for foundry and logic applications are expected to show stable growth of 6.7% year-over-year to $64.8 billion in 2025, driven by robust demand for advanced nodes. In 2026, the segment is forecast to grow another 6.6%, reaching $69.0 billion. The growth will be supported by increased capacity expansion purchases and rising demand for leading-edge technologies as the industry progresses toward high-volume manufacturing at the 2nm gate-all-around (GAA) node.

Memory-related capital expenditures are projected to see an increase in 2025 and to demonstrate continued growth in 2026. NAND equipment sales continue to recover from a sharp contraction of 2023. After registering a modest 4.1% increase in 2024, the NAND equipment market is expected to see 42.5% expansion to $13.7 billion in 2025 and 9.7% to $15.0 billion in 2026, driven by advancements in 3D NAND stacking and capacity expansion. Meanwhile, DRAM equipment sales, which surged 40.2% in 2024 to $19.5 billion, are projected to grow at 6.4% and 12.1% in 2025 and 2026, respectively, supporting investments in HBM for AI deployment.

Semiconductor Equipment Sales by Region

Mainland China, Taiwan and Korea are expected to remain the top three destinations for equipment spending through 2026. China continues to lead all regions over the forecast period, though sales in the region are expected to decline from 2024 record investments of $49.5 billion. All other regions except Europe are expected to see significant increases in equipment spending starting in 2025. However, heightened trade policy risks may impact the pace of growth across regions.

The SEMI forecast is based on collective input from top equipment suppliers, the SEMI Worldwide Semiconductor Equipment Market Statistics (WWSEMS) data collection program, and the industry-recognized SEMI World Fab Forecast database. 

About SEMI Market Data

The Equipment Market Data Subscription (EMDS) from SEMI provides comprehensive market data for the global semiconductor equipment market. A subscription includes three reports:

  • Monthly SEMI North American Billings Report, an early perspective of equipment market trends
  • Monthly Worldwide Semiconductor Equipment Market Statistics (WWSEMS), a detailed report of semiconductor equipment billings for seven regions and more than 22 market segments
  • Bi-annual Total Semiconductor Equipment Forecast – OEM Perspective, an outlook for the semiconductor equipment market

For more information on the report or to subscribe, please contact the SEMI Market Intelligence Team at mktstats@semi.org. Details on SEMI market data are available at SEMI Market Data.  

About SEMI

SEMI® is the global industry association connecting over 3,000 member companies and 1.5 million professionals worldwide across the semiconductor and electronics design and manufacturing supply chain. We accelerate member collaboration on solutions to top industry challenges through Advocacy, Workforce Development, Sustainability, Supply Chain Management and other programs. Our SEMICON® expositions and events, technology communities, standards and market intelligence help advance our members’ business growth and innovations in design, devices, equipment, materials, services and software, enabling smarter, faster, more secure electronics. Visit www.semi.org, contact a regional office, and connect with SEMI on LinkedIn and X to learn more.

Association Contact
Sherrie Gutierrez/SEMI
Phone: 1.831.889.3800
Email: sgutierrez@semi.org

SEMI 2025 Mid-Year Wafer Fab Equipment Forecast By Application
SEMI 2025 Mid-Year Wafer Fab Equipment Forecast By Application

 

 

BostonGene Receives Frost & Sullivan’s 2025 North American Enabling Technology Leadership Award for Redefining Precision Oncology with AI and Multiomics Innovation

BostonGene’s comprehensive AI-powered platform integrates multiomics data to accelerate discovery, reduce development risk and advance precision oncology across all stages the R&D continuum

SAN ANTONIO, July 22, 2025 /PRNewswire/ — Frost & Sullivan has named BostonGene the recipient of the 2025 North American Enabling Technology Leadership Award in recognition of the company’s pioneering role in advancing precision oncology. BostonGene’s clinically validated, AI-powered platform uses a multimodal approach to decode disease and uncover predictive biological signatures. 

BostonGene combines data from genes, RNA, proteins, the immune system and the tumor environment to help pharma and biotech develop targeted therapies, design efficient trials, and improve outcomes. Its “Comprehensive Digital Patient” model enables precise drug targeting, biomarker validation and patient stratification. With high test success and fast turnaround, BostonGene accelerates data-driven clinical decisions.

“BostonGene has developed state-of-the-art AI-driven, next-generation analytics technologies and is the only known source capable of delivering such comprehensive and integrated analyses,” said Unmesh Lal, Healthcare Research Director at Frost & Sullivan. “What truly differentiates BostonGene is its ability to turn vast, complex datasets into clinically meaningful insights with speed and accuracy—delivering real impact not just in research settings but in real-world clinical and drug development environments where timely, actionable data is critical.”

Backed by a decade of scientific investment and a growing intellectual property portfolio, BostonGene’s capabilities span internal lab services, advanced analytics and multimodal assay integration. Its CLIA-certified, CAP-accredited and NYS-approved regulatory infrastructure ensures quality and compliance across global partnerships.

“By delivering tailored solutions, accelerating project timelines and driving innovation through advanced analytics, BostonGene is fundamentally transforming oncology drug development,” said Manuel Albornoz, Best Practices Research Analyst at Frost & Sullivan. “Its adaptability, speed and scientific rigor make it a trusted partner for the industry.”

“This recognition reinforces our commitment to equipping drug developers with the tools they need to make smarter, faster decisions,” said Nathan Fowler, MD, Chief Medical Officer at BostonGene. “By integrating multiomic data and modeling the tumor microenvironment, we help our partners optimize trial design, improve patient selection and accelerate the development of targeted therapies.”

Each year, Frost & Sullivan presents this award to a company that has developed a breakthrough technology with the potential to significantly enhance existing products and enable the creation of new solutions and applications. The award highlights technologies with strong potential for market adoption and industry impact.

Frost & Sullivan Best Practices Awards honor companies across regional and global markets that demonstrate excellence in innovation, leadership, customer service and strategic product development. Recipients are selected through a rigorous evaluation process involving in-depth interviews, market analysis and extensive secondary research to identify companies that set the benchmark for industry best practices.

Read the final report here.

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, megatrends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Contact:

Ashley Shreve
Marketing Coordinator – Best Practices Recognition
Ashley.Weinkauf@frost.com 
Phone: +1.210.844.2505

About BostonGene Corporation

BostonGene helps drug developers de-risk and accelerate research and development using a clinically validated AI platform purpose-built for oncology and supported by a CLIA-certified and CAP-accredited clinical laboratory. By integrating advanced molecular and immune profiling with clinical data, we uncover actionable insights that inform trial design, optimize patient selection and improve clinical outcomes. Our diagnostic and treatment recommendation solutions are used in clinical settings to personalize care and guide therapy decisions for patients. For more information, visit www.BostonGene.com.For more information, visit www.BostonGene.com.

Contact:

Erin Keleher
Erin.Keleher@BostonGene.com
Phone: +1-617-283-2285